COMMUNIQUÉS West-GlobeNewswire

ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center

03/10/2018 - 13:08

RAMSEY, N.J. and MARIETTA, Ga., Oct. 03, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical company that develops, manufactures [...]

Myriad Genetics Announces Four Presentations at the 2018 American College of Rheumatology Annual Meeting

03/10/2018 - 13:05

SALT LAKE CITY, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that four studies on Vectra ® will be featured at the American College of [...]

Oasmia Presents Positive Efficacy and Safety Data for Doxophos Vet in Treatment of Naïve Dogs with Lymphoma

03/10/2018 - 13:00

Overall response rate data from the (RXE) Phase II study conducted in the US and Sweden met its primary end points and treatment with Doxophos Vet was generally well tolerated. Oasmia’s assessment is that the positive [...]

Emerald Health Therapeutics Enters Research Agreement with VivaCell Biotechnologies to Evaluate Proprietary Cannabis Products

03/10/2018 - 13:00

Research focused on supporting and validating Emerald’s intellectual property and development of its pipeline of proprietary cannabis products VICTORIA, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Emerald Health [...]

Summit Highlights Phase 3-Ready Precision Antibiotic Ridinilazole at IDWeek 2018

03/10/2018 - 13:00

Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Highlights Phase 3-Ready Precision Antibiotic Ridinilazole at IDWeek 2018 Ridinilazole in Development to Treat C. difficile Infection and Reduce Recurrent [...]

Aclaris Therapeutics Announces Poster Presentations at 2018 American Society for Dermatologic Surgery Annual Meeting and Fall Clinical Dermatology Conference

03/10/2018 - 13:00

WAYNE, Pa., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]

Optinose to Highlight Data at Two Upcoming Scientific Meetings

03/10/2018 - 13:00

YARDLEY, Pa., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that data concerning [...]

Neon Therapeutics to Present Data from Ongoing Phase 1b NT-001 Clinical Trial at the European Society for Medical Oncology 2018 Congress

03/10/2018 - 13:00

Company to Host Investor Conference Call and Webcast on October 22, 2018 at 8:00 a.m. ET CAMBRIDGE, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology [...]

T2 Biosystems Announces Customer Presentations at October Conferences

03/10/2018 - 13:00

IDWeek and World Antimicrobial Resistance Congress to feature presentations on T2Bacteria and T2Candida Panels LEXINGTON, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the [...]

Capricor Therapeutics to Present at 2018 Cell & Gene Meeting on the Mesa

03/10/2018 - 13:00

Company will Provide Presentation on Cell and Exosome Therapies and Poster on New Research LA JOLLA, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc . (NASDAQ: CAPR) will provide a presentation at [...]

BeyondSpring to Present Clinical Trial Data at Three Upcoming Scientific Conferences

03/10/2018 - 12:56

NEW YORK, Oct. 03, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global, clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, announced today that the Company [...]

Tetra Bio-Pharma Moves PPP001 Closer to Commercial Manufacturing with the Issuance of a Drug Establishment License to Ford’s Pharmacy

03/10/2018 - 12:30

ORLEANS, Ontario, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), in partnership with Ford’s Family Pharmacy and [...]

TRU NIAGEN® PRO to be Featured at the North American Menopause Society (NAMS) Annual Meeting

03/10/2018 - 12:30

Women’s health practitioners now have access to TRU NIAGEN® PRO for aging patients LOS ANGELES, Oct. 03, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that it will highlight its new TRU NIAGEN [...]

BrainStorm Highlights Translational Data and Presentations Supporting NUROWN® Technology Platform as a Best-In-Class Strategy in ALS

03/10/2018 - 12:10

NurOwn® to be Featured at NEALS and Cell & Gene Meeting on the Mesa Conferences NEW YORK and PETACH TIKVAH, Israel, Oct. 03, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading [...]

Wright Medical Group N.V. to Host Third Quarter 2018 Earnings Conference Call

03/10/2018 - 12:00

Wednesday, November 7, 2018, at 3:30 p.m. Central / 4:30 p.m. Eastern AMSTERDAM, The Netherlands, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today announced that it will host a conference [...]

Adherium Announces Participation in SmartAirLA Effort to Combat Asthma in Los Angeles with Support from Blue Shield of California Foundation

03/10/2018 - 12:00

The Program Aims In Part to Develop Better Models for Expanding Data-Based Medication Adherence SAN MATEO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a leading digital health platform for medication [...]

Horizon Discovery enters into license agreement with Cytovance Biologics for HD-BIOP3 Suspension adapted GS null CHO K1 cells

03/10/2018 - 11:00

OKLAHOMA CITY, Okla., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Cytovance® Biologics, Inc. signed a non-exclusive license with Horizon Discovery for the use of their HD-BIOP3 Suspension adapted GS null CHO K1 cells. The Horizon [...]

Motif Bio Presents New Iclaprim Data at IDWeek

03/10/2018 - 09:01

Iclaprim safety and efficacy in patients with wound infections in REVIVE Phase 3 trials NEW YORK, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company [...]

Rule 2.9 Announcement

03/10/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 3 October 2018 [...]